MDA-MB-231细胞专用培养基(DMEM)

一键复制产品信息

参考文献

• PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis (2023-06-01)

  作者：Zhe Wang:1.Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; 2.The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; Ruolei Li:1.Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; 2.The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; Niuniu Hou:1.Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China. ; 2.Department of General Surgery, Eastern Theater Air Force Hospital of PLA, Nanjing, Jiangsu, People's Republic of China. ; Juliang Zhang:1.Department o

  期刊：PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis

  DOI：10.1136/jitc-2023-006890

  影响因子 ：10.9

  引用产品： MDA-MB-231 细胞 ,  MDA-MB-231细胞专用培养基 (L15) ,  4T1 细胞 ,  4T1细胞专用培养基

• CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis (2023-06-09)

  作者：Jiulong Ma:1.Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China. ; Chen Chen:1.Department of Pharmacology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China. ; Zhimin Fan:1.General Surgery Center, Department of Breast Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, China. ; Yang Zhang:1.Department of Rehabilitation Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. ; Jiahua Ji:1.Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China. ; Dexian Wei:1.Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, China. ; Fan Zhang:1.General Surgery Center, Department of Breast Surgery, The Firs

  期刊：CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis

  DOI：10.1016/j.ijbiomac.2023.125295

  影响因子 ：8.2

  引用产品： MCF 10A 细胞 ,  BT-474 [BT474] 细胞 ,  SK-BR-3 [SKBR3] 细胞 ,  MDA-MB-231 细胞 ,  MCF 10A细胞专用培养基 ,  BT-474 [BT474]细胞专用培养基 ,  SK-BR-3 [SKBR3]细胞专用培养基 ,  MDA-MB-231细胞专用培养基 (L15)

• A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis (2023-03-25)

  作者：Ran Hao:1.Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China. ; Lei Zhang:1.Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China. ; Yangming Si:1.School of Physical Science and Technology, Inner Mongolia University, Hohhot, Inner Mongolia, China. ; Peng Zhang:1.Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China. ; 2.Department of Military Nursing, NCO School, Army Medical University, Shijiazhuang, Hebei, China. ; Yipeng Wang:1.Institutes of Health Research, Hebei Medical University, Shijiazhuang, Hebei, China. ; Bangchao Li:1.Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. ; Jie Hu:1.Department of Science and Technology, Hebei Medical University, Shijiazhuang, Hebei, China. Hujie@hebmu.edu.cn. ; Yixin Qi:1.Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. qiyixin@hebmu.ed

  期刊：A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis

  DOI：10.1186/s12935-023-02895-w

  影响因子 ：5.8

  引用产品： MCF 10A 细胞 ,  BT-474 [BT474] 细胞 ,  BT-549 细胞 ,  MCF7 [MCF-7] 细胞 ,  MDA-MB-231 细胞 ,  MDA-MB-231 细胞 ,  MDA-MB-453 细胞 ,  MDA-MB-453 细胞 ,  T-47D 细胞 ,  MCF 10A细胞专用培养基 ,  BT-474 [BT474]细胞专用培养基 ,  BT-549细胞专用培养基 ,  MCF7 [MCF-7]细胞专用培养基 ,  MDA-MB-231细胞专用培养基 (L15) ,  MDA-MB-231细胞专用培养基 (DMEM) ,  MDA-MB-453细胞专用培养基 (L15)

• Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma (2023-08-04)

  作者：Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Tong Guo:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Chenguang Zhang:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Yutian Sun:1.Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. ; Jianghua Ou:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. ; Shang Ying Wu:1.Depa

  期刊：Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma

  DOI：10.3389/fendo.2023.1179050

  影响因子 ：5.2

  引用产品： MCF7 [MCF-7] 细胞 ,  BT-20 细胞 ,  MDA-MB-231 细胞 ,  HCC1806 细胞 ,  HCC1937 细胞 ,  MCF7 [MCF-7]细胞专用培养基 ,  BT-20细胞专用培养基 ,  MDA-MB-231细胞专用培养基 (L15) ,  HCC1806细胞专用培养基 ,  HCC1937细胞专用培养基

• Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity (2023-07-08)

  作者：Yuting Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. ; Yinghui Ye:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Anping Xu:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. ; Yulou Luo:1.Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, China. ; Yutian Sun:1.Department of Medical Oncology, School of Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, 610000, China. ; Wei Zhang:1.Department of Breast Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, 510000, China. zhangwei@jnu.edu.cn. ; Ling Ji:1.Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, 518000, China. 1120303921@qq.com. ;

  期刊：Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity

  DOI：10.1007/s00432-023-05028-y

  影响因子 ：3.6

  引用产品： MCF7 [MCF-7] 细胞 ,  MCF7 [MCF-7]细胞专用培养基 ,  BT-20 细胞 ,  BT-20细胞专用培养基 ,  MDA-MB-231 细胞 ,  MDA-MB-231细胞专用培养基 (L15) ,  MDA-kb2 细胞 ,  MDA-kb2细胞专用培养基 (L15) ,  HCC1937 细胞 ,  HCC1937细胞专用培养基

• Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression (2023-04-03)

  作者：Chao Yan:1.Medical Laboratory, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an 223003, Jiangsu, China. ; Yue Jin:1.Medical Laboratory, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, No. 62, Huaihai South Road, Qingjiangpu District, Huai'an 223003, Jiangsu, China. ;

  期刊：Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression

  DOI：10.1515/med-2023-0676

  影响因子 ：2.1

  引用产品： MDA-MB-231细胞专用培养基 (L15) ,  SK-BR-3 [SKBR3]细胞专用培养基 ,  BT-20细胞专用培养基 ,  MDA-MB-436细胞专用培养基 (L15)

• Asiaticoside hampers epithelial–mesenchymal transition by promoting PPARG expression and suppressing P2RX7-mediated TGF-β/Smad signaling in triple-negative breast cancer (2022-11-28)

  作者：Xuemei Huang:1.Department of Oncology and Hematology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. ; Zhiqin Jia:1.Department of Obstetrics and Gynecology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. ; Xiangyue Li:1.Department of Obstetrics and Gynecology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. ; Zhilan Hu:1.Department of Obstetrics and Gynecology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. ; Xiaolan Yu:1.Department of Obstetrics and Gynecology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. ; Jiyi Xia:1.Department of Oncology and Hematology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China. ; 2.Dazhou Vocational College of Chinese Medicine, Dazhou,

  期刊：Asiaticoside hampers epithelial–mesenchymal transition by promoting PPARG expression and suppressing P2RX7-mediated TGF-β/Smad signaling in triple-negative breast cancer

  DOI：10.1002/ptr.7692

  影响因子 ：6.4

  引用产品： 人乳腺上皮细胞 ,  MDA-MB-453 细胞 ,  MDA-MB-231细胞专用培养基 (DMEM) ,  MCF7 [MCF-7] 细胞 ,  ZR-75-1 细胞

• RNA Hydrogel Combined with MnO2 Nanoparticles as a Nano-Vaccine to Treat Triple Negative Breast Cancer (2012-01-20)

  作者：Weicai Wang:1.Collaborative Innovation Center of Tumor Marker Detection Technology, Equipment and Diagnosis-Therapy Integration in Universities of Shandong, Shandong Province Key Laboratory of Detection Technology for Tumor Makers, School of Chemistry and Chemical Engineering, Linyi University, Linyi, China. ; Xiaofan Liu:1.Collaborative Innovation Center of Tumor Marker Detection Technology, Equipment and Diagnosis-Therapy Integration in Universities of Shandong, Shandong Province Key Laboratory of Detection Technology for Tumor Makers, School of Chemistry and Chemical Engineering, Linyi University, Linyi, China. ; Lairong Ding:1.Collaborative Innovation Center of Tumor Marker Detection Technology, Equipment and Diagnosis-Therapy Integration in Universities of Shandong, Shandong Province Key Laboratory of Detection Technology for Tumor Makers, School of Chemistry and Chemical Engineering, Linyi University, Linyi, China. ; Hyung Jong Jin:1.Department of Bioscience and Biotechnology,

  期刊：RNA Hydrogel Combined with MnO2 Nanoparticles as a Nano-Vaccine to Treat Triple Negative Breast Cancer

  DOI：10.3389/fchem.2021.797094

  影响因子 ：5.5

  引用产品： MDA-MB-231细胞专用培养基 (DMEM)

• CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer (2010-01-20)

  作者：Li Ding:1.Department of Pediatric breast surgery, The First People's Hospital of Huaihua City, Hunan, China. Electronic address: dingli5506@163.com. ; Zhibing Xie:1.Department of Infectious Disease Center, The First People's Hospital of Huaihua City, Hunan, China. ;

  期刊：CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer

  DOI：10.1016/j.yexmp.2021.104704

  影响因子 ：4.4

  引用产品： MCF 10A 细胞 ,  T-47D 细胞 ,  MCF7 [MCF-7] 细胞 ,  MDA-MB-231细胞专用培养基 (DMEM) ,  BT-549 细胞 ,  SK-BR-3 [SKBR3] 细胞

点击展开收起列表